American Assets Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History

American Assets Investment Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,500	Closed	-$276K	–	163
2021 Q2	$276K	Hold	1,500	–	–	0.04%	130
2021 Q1	$229K	Hold	1,500	–	–	0.03%	147
2020 Q4	$234K	Buy	+1,500	New	+$193K	0.04%	124
2020 Q2	–	Sell	-5,000	Closed	-$449K	–	171
2020 Q1	$449K	Buy	5,000 +1,500	+43%	+$147K	0.1%	149
2019 Q4	$379K	Hold	3,500	–	–	0.06%	164
2019 Q3	$343K	Hold	3,500	–	–	0.06%	163
2019 Q2	$458K	Hold	3,500	–	–	0.07%	158
2019 Q1	$466K	Hold	3,500	–	–	0.08%	159
2018 Q4	$341K	Hold	3,500	–	–	0.06%	162
2018 Q3	$484K	Hold	3,500	–	–	0.08%	160
2018 Q2	$426K	Buy	3,500 +1,000	+40%	+$117K	0.07%	162
2018 Q1	$279K	Buy	+2,500	New	+$299K	0.05%	172

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

American Assets Investment Management's ALXN Position: Q3 2021 in Review

American Assets Investment Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 1,500 shares — an estimated $276K sold.

American Assets Investment Management first reported a position in ALXN in Q1 2018 and held it in 12 quarters. The position peaked at $484K in Q3 2018. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

American Assets Investment Management reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
American Assets Investment Management sold 1,500 Alexion Pharmaceuticals shares in Q3 2021, an estimated $276K.
American Assets Investment Management first reported a position in Alexion Pharmaceuticals in Q1 2018 and held it in 12 quarters.
American Assets Investment Management's Alexion Pharmaceuticals position peaked at $484K in Q3 2018.
7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on American Assets Investment Management's 13F filing for Q3 2021, filed 21 Oct 2021.